GLPG0259

DRUG3 trials

Sponsors

Galapagos NV

Conditions

Healthy

Phase 1

First-in-Human Single Ascending and Multiple Dose of GLPG0259

CompletedNCT00905138

Galapagos NVHealthy

Start: 2009-03-31End: 2009-06-30Updated: 2012-02-20

GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy Subjects

CompletedNCT00989703

Galapagos NVHealthy

Start: 2009-09-30End: 2010-01-31Updated: 2012-02-20

GLPG0259 Solid Formulation Bioavailability and Food Effect

CompletedNCT01024517

Galapagos NVHealthy

Start: 2009-11-30End: 2010-02-28Updated: 2010-04-27